US Stock MarketDetailed Quotes
FNCH Finch Therapeutics
- 2.3200
- +0.0800+3.57%
Close Apr 26 16:00 ET
- 2.2800
- -0.0400-1.72%
Post 18:35 ET
3.73MMarket Cap-49P/E (TTM)
2.4300High2.0950Low38.24KVolume2.2400Open2.2400Pre Close87.08KTurnover4.82%Turnover RatioLossP/E (Static)1.61MShares16.740052wk High0.16P/B1.84MFloat Cap1.860052wk Low--Dividend TTM792.86KShs Float675.0000Historical High--Div YieldTTM14.96%Amplitude1.8600Historical Low2.2770Avg Price1Lot Size
Finch Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 57.91%-31.51M | 74.03%-3.71M | 72.45%-5.26M | 42.19%-9.16M | 47.82%-13.38M | -11.50%-74.85M | -3.52%-14.27M | -33.07%-19.09M | 33.40%-15.84M | -68.57%-25.65M |
| Net income from continuing operations | 34.80%-74.75M | 88.74%-3.04M | 94.02%-2.42M | 76.40%-5.36M | -160.26%-63.94M | -97.12%-114.65M | -41.74%-27.01M | -305.53%-40.37M | -49.65%-22.7M | -75.72%-24.57M |
| Operating gains losses | 10,314.29%729K | -4,300.00%-42K | --22K | ---797K | --1.55M | 100.38%7K | --1K | --0 | ---- | ---- |
| Depreciation and amortization | -72.40%1.52M | -96.88%44K | -96.30%52K | -95.82%57K | 2.70%1.37M | 139.33%5.51M | 107.67%1.41M | 120.22%1.41M | 120.91%1.36M | 261.68%1.33M |
| Deferred tax | ---3.46M | --0 | --0 | --0 | ---3.46M | --0 | --0 | --0 | --0 | --0 |
| Other non cash items | -36.68%1.91M | -99.51%5K | -28.10%719K | -73.06%205K | 305.79%982K | 230.56%3.02M | 324.69%1.02M | 327.35%1M | 232.31%761K | 14.69%242K |
| Change In working capital | -246.55%-5.42M | -149.34%-786K | -208.94%-3.97M | -222.85%-3.56M | 160.83%2.9M | 89.22%-1.56M | -45.91%1.59M | 81.04%-1.29M | 134.01%2.9M | -122.26%-4.77M |
| -Change in receivables | -59.14%143K | 99.31%-1K | --0 | 5,450.00%107K | -88.51%37K | -41.76%350K | -107.56%-144K | 216.78%174K | -103.77%-2K | 126.66%322K |
| -Change in prepaid assets | 183.87%2.12M | -105.52%-108K | 249.73%1.31M | -139.87%-842K | 125.29%1.76M | 21.39%-2.53M | 148.78%1.96M | -81.75%374K | 158.63%2.11M | -397.35%-6.97M |
| -Change in payables and accrued expense | -334.47%-8.79M | -611.76%-435K | -703.61%-5.01M | 56.57%-2.05M | -172.17%-1.29M | -127.21%-2.02M | -98.63%85K | -65.16%830K | -1,375.94%-4.72M | 319.41%1.79M |
| -Change in other current assets | 514.79%4.03M | --0 | --0 | --0 | 1,011.02%4.03M | 113.99%656K | --0 | --348K | 98.56%-55K | --363K |
| -Change in other current liabilities | -248.01%-2.93M | 20.13%-242K | 91.00%-271K | -113.97%-778K | -501.10%-1.64M | 296.92%1.98M | -13.06%-303K | -1,085.83%-3.01M | 2,318.73%5.57M | -17.17%-273K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 57.91%-31.51M | 74.03%-3.71M | 72.45%-5.26M | 42.19%-9.16M | 47.82%-13.38M | -11.50%-74.85M | -3.52%-14.27M | -33.07%-19.09M | 33.40%-15.84M | -68.57%-25.65M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 160.82%1.33M | 200.00%51K | 106.10%20K | 242.06%1.27M | 98.46%-14K | 86.29%-2.18M | 97.45%-51K | 86.13%-328K | 67.26%-894K | 89.70%-909K |
| Net PPE purchase and sale | 160.82%1.33M | 200.00%51K | 106.10%20K | 242.06%1.27M | 98.46%-14K | 86.29%-2.18M | 97.45%-51K | 86.13%-328K | 67.26%-894K | 89.70%-909K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 160.82%1.33M | 200.00%51K | 106.10%20K | 242.06%1.27M | 98.46%-14K | 86.29%-2.18M | 97.45%-51K | 86.13%-328K | 67.26%-894K | 89.70%-909K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -208.62%-16.16M | 0 | 0 | -99.97%4K | -323,280.00%-16.16M | -87.51%14.87M | -25.71%52K | -8.89%41K | 807.56%14.78M | -100.00%5K |
| Net issuance payments of debt | -209.78%-16.16M | -14,337.50%-1.16M | --0 | -99.97%4K | -166,611.11%-15M | 54,603.70%14.72M | -300.00%-8K | 25.00%-3K | 113,453.85%14.74M | -12.50%-9K |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | --0 | --0 | -91.02%289K | -15.49%60K | -10.20%44K | -94.39%171K | -74.07%14K |
| Net other financing activities | ---- | ---- | --0 | --0 | ---1.16M | 95.04%-132K | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -208.62%-16.16M | --0 | --0 | -99.97%4K | -323,280.00%-16.16M | -87.51%14.87M | -25.71%52K | -8.89%41K | 807.56%14.78M | -100.00%5K |
| Net cash flow | ||||||||||
| Beginning cash position | -45.72%73.81M | -64.66%31.13M | -66.15%36.37M | -59.56%44.25M | -45.72%73.81M | 36.09%135.97M | -41.93%88.08M | -36.17%107.46M | -43.38%109.42M | 36.09%135.97M |
| Current changes in cash | 25.46%-46.33M | 74.39%-3.66M | 72.95%-5.24M | -302.55%-7.88M | -11.31%-29.55M | -272.40%-62.16M | 9.21%-14.27M | -16.28%-19.38M | 92.13%-1.96M | -128.45%-26.55M |
| End cash Position | -62.78%27.47M | -62.78%27.47M | -64.66%31.13M | -66.15%36.37M | -59.56%44.25M | -45.72%73.81M | -45.72%73.81M | -41.93%88.08M | -36.17%107.46M | -43.38%109.42M |
| Free cash flow | 59.10%-31.51M | 74.22%-3.69M | 72.91%-5.26M | 45.28%-9.16M | 49.56%-13.4M | 7.32%-77.03M | 9.28%-14.32M | -16.21%-19.42M | 37.01%-16.73M | -10.42%-26.56M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg